Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Posaconazole concentrations in the central nervous system.

Literature DB >> 18824458

Posaconazole concentrations in the central nervous system.

Maria J G T Rüping, Nadine Albermann, Friedrich Ebinger, Irene Burckhardt, Claudia Beisel, Carsten Müller, Jörg J Vehreschild, Matthias Kochanek, Gerd Fätkenheuer, Christopher Bangard, Andrew J Ullmann, Wolfgang Herr, Karin Kolbe, Michael Hallek, Oliver A Cornely.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2008 PMID： 18824458 DOI： 10.1093/jac/dkn409

Source DB: PubMed Journal: J Antimicrob Chemother ISSN： 0305-7453 Impact factor: 5.790

Keyword Cloud
Cited

× No keyword cloud information.

32 in total

1. Clinical pharmacodynamics and pharmacokinetics of the antifungal extended-spectrum triazole posaconazole: an overview.

Authors: Hans-Peter Lipp
Journal: Br J Clin Pharmacol Date: 2010-10 Impact factor: 4.335

2. Visual Hallucinations Associated with High Posaconazole Concentrations in Serum.

Authors: Leighanne O Parkes; Matthew P Cheng; Donald C Sheppard
Journal: Antimicrob Agents Chemother Date: 2015-12-07 Impact factor: 5.191

3. Antifungal susceptibility patterns of opportunistic fungi in the genera Verruconis and Ochroconis.

Authors: S Seyedmousavi; K Samerpitak; A J M M Rijs; W J G Melchers; J W Mouton; P E Verweij; G S de Hoog
Journal: Antimicrob Agents Chemother Date: 2014-03-31 Impact factor: 5.191

4. Low Central Nervous System Posaconazole Concentrations during Cerebral Phaeohyphomycosis.

Authors: François Barde; Eliane Billaud; Lauriane Goldwirt; Catherine Horodyckid; Vincent Jullien; Fanny Lanternier; Philippe Lesprit; Lucie Limousin; Jérémie F Cohen; Olivier Lortholary
Journal: Antimicrob Agents Chemother Date: 2019-10-22 Impact factor: 5.191

10. Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection.

Authors: M Mar Rodríguez; F Javier Pastor; Enrique Calvo; Valentina Salas; Deanna A Sutton; Josep Guarro
Journal: Antimicrob Agents Chemother Date: 2009-09-28 Impact factor: 5.191

Posaconazole concentrations in the central nervous system.

1. Clinical pharmacodynamics and pharmacokinetics of the antifungal extended-spectrum triazole posaconazole: an overview.

2. Visual Hallucinations Associated with High Posaconazole Concentrations in Serum.

3. Antifungal susceptibility patterns of opportunistic fungi in the genera Verruconis and Ochroconis.

4. Low Central Nervous System Posaconazole Concentrations during Cerebral Phaeohyphomycosis.

5. Isavuconazole treatment of a patient with disseminated mucormycosis.

Review 6. Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.

7. Reflections on the approach to treatment of a mycologic disaster.

Review 8. Pharmacokinetic/pharmacodynamic profile of posaconazole.

9. First autochthonous case of Rhinocladiella mackenziei cerebral abscess outside the Middle East.

10. Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection.